Real-Life Experience of a Brief Arsenic Trioxide-Based Consolidation Chemotherapy in the Management of Acute Promyelocytic Leukemia: Favorable Outcomes With Limited Anthracycline Exposure and Shorter Consolidation Therapy-Reference-Cited by-同舟云学术

Real-Life Experience of a Brief Arsenic Trioxide-Based Consolidation Chemotherapy in the Management of Acute Promyelocytic Leukemia: Favorable Outcomes With Limited Anthracycline Exposure and Shorter Consolidation Therapy

Published:2015-05 Issue:5 Volume:15 Page:292-297
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Leech Mindy,Morris Lawrence,Stewart Moishe,Smith B. Douglas,Bashey Asad,Holland Kent,Solomon Scott,Zhang Xu,Carraway Hetty E.,Pratz Keith,Gore Steven D.,Zeidan Amer M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference21 articles.

1. AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance;Avvisati;Blood,2011

2. Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710;Powell;Blood,2010

3. Cardiotoxicity of cancer therapy;Floyd;J Clin Oncol,2005

4. Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia;Thomas;Ann Hematol,2002

5. Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience;Lobe;Leukemia,2003

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro and ex vivo anti-myeloma effects of nanocomposite As4S4/ZnS/Fe3O4;Scientific Reports;2022-10-26

2. Evaluation of arsenic species in leukocytes and granulocytes of acute promyelocytic leukemia patients treated with arsenic trioxide;Journal of Pharmaceutical and Biomedical Analysis;2021-09

3. Realgar nanoparticlesversusATO arsenic compounds inducein vitroandin vivoactivityagainstmultiple myeloma;British Journal of Haematology;2017-10-19

4. First-Line Therapy: ATRA-ATO/Reduced Chemotherapy Approach;Acute Promyelocytic Leukemia;2017-09-26

5. Acute Promyelocytic Leukemia;Neoplastic Diseases of the Blood;2017-09-09